Nuventa Enterprises Llp
Founded: 2017
Status: Strike Off
Designation: Designated Partner
MA
Manisha Yogesh Agrawal, Designated Partner and Director, with 61 companies.
Manisha Yogesh Agrawal has 25 years in corporate governance. Holds Designated Partner and Director roles. Currently with 29 companies, including Nuventa Enterprises Llp and Nuventa Pharma Llp. Formerly with 32 companies, such as Riteaid Finance Private Limited and Axera Enterprises Private Limited. Engaged in General Business, Healthcare and more. Contributes to corporate operations.
Founded: 2017
Status: Strike Off
Designation: Designated Partner
Founded: 2016
Status: Strike Off
Designation: Designated Partner
Founded: 2016
Status: Strike Off
Designation: Designated Partner
Founded: 2016
Status: Strike Off
Designation: Designated Partner
Founded: 2016
Status: Strike Off
Designation: Designated Partner
Founded: 2016
Status: Strike Off
Designation: Designated Partner
Founded: 2017
Status: Under Process Of Striking Off
Designation: Director
Founded: 2018
Status: Active
Designation: Director
Founded: 2007
Status: Converted To Llp
Designation: Director
Founded: 2007
Status: Strike Off
Designation: Additional Director
Founded: 1988
Status: Active
Designation: Additional Director
Founded: 2007
Status: Strike Off
Designation: Additional Director
Explore Director's current and past company associations— Uncover their professional journey today!
Manisha Yogesh Agrawal has 25 years in corporate governance. Holds Designated Partner and Director roles. Currently with 29 companies, including Nuventa Enterprises Llp and Nuventa Pharma Llp. Formerly with 32 companies, such as Riteaid Finance Private Limited and Axera Enterprises Private Limited. Engaged in General Business, Healthcare and more. Contributes to corporate operations.
Manisha Yogesh Agrawal is associated with 29 companies as Designated Partner and Director.
Manisha Yogesh Agrawal has expertise in General Business, Healthcare and other sectors.
Manisha Yogesh Agrawal has 25 years in corporate governance.